Table 3 Patient characteristics of patients that had follow-up information available at 12 and 6 months after treatment.
From: Delta-radiomics features during radiotherapy improve the prediction of late xerostomia
Follow-up info at 12 months | Follow-up info at 6 months | |||
|---|---|---|---|---|
Characteristics | N = 68 | % | N = 88 | % |
Sex | ||||
Female | 20 | 29 | 26 | 30 |
Male | 48 | 71 | 62 | 70 |
Age | ||||
18–65 | 48 | 71 | 62 | 70 |
>65 | 20 | 29 | 26 | 30 |
Tumour site | ||||
Oropharynx | 22 | 32 | 27 | 31 |
Hypopharynx | 0 | 0 | 1 | 1 |
Nasopharynx | 5 | 7 | 5 | 6 |
Larynx | 22 | 32 | 27 | 31 |
Oral cavity | 15 | 22 | 23 | 26 |
Unknown primary | 1 | 1 | 1 | 1 |
Other | 3 | 4 | 4 | 5 |
Tumour classification | ||||
T0 | 1 | 1 | 1 | 1 |
T1 | 11 | 16 | 14 | 16 |
T2 | 14 | 21 | 19 | 22 |
T3 | 17 | 25 | 19 | 22 |
T4 | 23 | 34 | 33 | 38 |
Unknown | 2 | 3 | 2 | 2 |
Node classification | ||||
N0 | 23 | 34 | 28 | 33 |
N1 | 9 | 13 | 13 | 15 |
N2abc | 31 | 46 | 41 | 47 |
N3 | 3 | 4 | 4 | 5 |
Systemic treatment | ||||
Yes | 34 | 50 | 47 | 53 |
No | 34 | 50 | 41 | 47 |
Treatment technique | ||||
IMRT | 27 | 40 | 30 | 34 |
VMAT | 41 | 60 | 58 | 66 |
Bilateral | ||||
Yes | 57 | 84 | 72 | 82 |
no | 11 | 16 | 16 | 18 |
Baseline xerostomia | ||||
Any | 26 | 38 | 36 | 41 |
None | 42 | 62 | 52 | 59 |
